Sale!

EGR2 Gene CMT1D Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The EGR2 Gene CMT1D Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the EGR2 gene, which are associated with Charcot-Marie-Tooth disease type 1D (CMT1D). CMT1D is a type of inherited neurological disorder that affects the peripheral nerves, leading to muscle weakness and sensory problems primarily in the arms and legs. The test plays a crucial role in the early detection and management of the condition, allowing for personalized treatment plans and genetic counseling for affected individuals and their families. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test is priced at 4400 AED, reflecting the intricate technology and expertise involved in detecting the specific genetic alterations linked to CMT1D.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

EGR2 Gene CMT1D Genetic Test

Test Name: EGR2 Gene CMT1D Genetic Test

Components: NGS Technology

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for EGR2 Gene CMT1D NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with EGR2 Gene CMT1D.

Test Details

The EGR2 gene is associated with Charcot-Marie-Tooth disease type 1D (CMT1D), a genetic disorder that affects the peripheral nerves. The EGR2 gene provides instructions for making a protein called early growth response 2, which plays a role in the development and maintenance of the myelin sheath that surrounds and protects nerve fibers.

NGS (next-generation sequencing) genetic testing can be used to analyze the DNA sequence of the EGR2 gene and identify any mutations or variations that may be responsible for CMT1D. This type of genetic testing can help diagnose the condition and provide information about the inheritance pattern and risk of passing the condition on to future generations.

NGS genetic testing for CMT1D typically involves collecting a sample of DNA from the patient, which can be obtained through a blood sample or a cheek swab. The DNA is then analyzed using specialized sequencing technology to identify any mutations or variations in the EGR2 gene.

Results of the NGS genetic test can help healthcare providers develop an appropriate treatment plan for individuals with CMT1D and provide genetic counseling to affected individuals and their families.

Test Name EGR2 Gene CMT1D Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for EGR2 Gene CMT1D NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with EGR2 Gene CMT1D
Test Details

The EGR2 gene is associated with Charcot-Marie-Tooth disease type 1D (CMT1D), a genetic disorder that affects the peripheral nerves. The EGR2 gene provides instructions for making a protein called early growth response 2, which plays a role in the development and maintenance of the myelin sheath that surrounds and protects nerve fibers.

NGS (next-generation sequencing) genetic testing can be used to analyze the DNA sequence of the EGR2 gene and identify any mutations or variations that may be responsible for CMT1D. This type of genetic testing can help diagnose the condition and provide information about the inheritance pattern and risk of passing the condition on to future generations.

NGS genetic testing for CMT1D typically involves collecting a sample of DNA from the patient, which can be obtained through a blood sample or a cheek swab. The DNA is then analyzed using specialized sequencing technology to identify any mutations or variations in the EGR2 gene.

Results of the NGS genetic test can help healthcare providers develop an appropriate treatment plan for individuals with CMT1D and provide genetic counseling to affected individuals and their families.